Arbutus Biopharma Statistics
Total Valuation
ABUS has a market cap or net worth of $869.30 million. The enterprise value is $787.90 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ABUS has 192.32 million shares outstanding. The number of shares has increased by 5.88% in one year.
| Current Share Class | 192.32M |
| Shares Outstanding | 192.32M |
| Shares Change (YoY) | +5.88% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 48.89% |
| Float | 126.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 59.35 |
| Forward PS | 573.20 |
| PB Ratio | 11.26 |
| P/TBV Ratio | 11.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 53.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.80, with a Debt / Equity ratio of 0.06.
| Current Ratio | 18.80 |
| Quick Ratio | 18.31 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -287.66 |
Financial Efficiency
Return on equity (ROE) is -45.88% and return on invested capital (ROIC) is -20.03%.
| Return on Equity (ROE) | -45.88% |
| Return on Assets (ROA) | -16.46% |
| Return on Invested Capital (ROIC) | -20.03% |
| Return on Capital Employed (ROCE) | -33.89% |
| Revenue Per Employee | $331,955 |
| Profits Per Employee | -$960,841 |
| Employee Count | 44 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +43.89% in the last 52 weeks. The beta is 0.66, so ABUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +43.89% |
| 50-Day Moving Average | 4.49 |
| 200-Day Moving Average | 3.76 |
| Relative Strength Index (RSI) | 52.37 |
| Average Volume (20 Days) | 1,057,367 |
Short Selling Information
The latest short interest is 11.21 million, so 5.83% of the outstanding shares have been sold short.
| Short Interest | 11.21M |
| Short Previous Month | 10.56M |
| Short % of Shares Out | 5.83% |
| Short % of Float | 8.89% |
| Short Ratio (days to cover) | 10.42 |
Income Statement
In the last 12 months, ABUS had revenue of $14.61 million and -$42.28 million in losses. Loss per share was -$0.22.
| Revenue | 14.61M |
| Gross Profit | -14.44M |
| Operating Income | -31.36M |
| Pretax Income | -42.28M |
| Net Income | -42.28M |
| EBITDA | -30.67M |
| EBIT | -31.36M |
| Loss Per Share | -$0.22 |
Full Income StatementBalance Sheet
The company has $93.70 million in cash and $4.61 million in debt, giving a net cash position of $89.10 million or $0.46 per share.
| Cash & Cash Equivalents | 93.70M |
| Total Debt | 4.61M |
| Net Cash | 89.10M |
| Net Cash Per Share | $0.46 |
| Equity (Book Value) | 77.40M |
| Book Value Per Share | 0.40 |
| Working Capital | 92.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$45.27 million and capital expenditures -$86,000, giving a free cash flow of -$45.36 million.
| Operating Cash Flow | -45.27M |
| Capital Expenditures | -86,000 |
| Free Cash Flow | -45.36M |
| FCF Per Share | -$0.24 |
Full Cash Flow StatementMargins
Gross margin is -98.86%, with operating and profit margins of -214.67% and -289.45%.
| Gross Margin | -98.86% |
| Operating Margin | -214.67% |
| Pretax Margin | -289.45% |
| Profit Margin | -289.45% |
| EBITDA Margin | -209.98% |
| EBIT Margin | -214.67% |
| FCF Margin | n/a |
Dividends & Yields
ABUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.88% |
| Shareholder Yield | -5.88% |
| Earnings Yield | -4.82% |
| FCF Yield | -5.17% |
Analyst Forecast
The average price target for ABUS is $5.00, which is 10.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 10.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABUS has an Altman Z-Score of 0.23 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.23 |
| Piotroski F-Score | 4 |
